Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 04, 2024

SELL
$72.62 - $79.98 $4.07 Million - $4.48 Million
-56,000 Closed
0 $0
Q4 2021

Aug 22, 2024

BUY
$53.63 - $62.52 $3 Million - $3.5 Million
56,000 New
56,000 $3.49 Billion
Q1 2021

Sep 04, 2024

BUY
$59.34 - $66.74 $3.32 Million - $3.74 Million
56,000 New
56,000 $3.54 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Portfolio

Follow Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group, based on Form 13F filings with the SEC.

News

Stay updated on Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group with notifications on news.